Chronic viral hepatitis is prevalent worldwide
in the pediatric population and can be associated with significant
morbidity and mortality. Acquisition of disease in early childhood
may predispose children to long-term complications, including
cirrhosis and HCC. Efforts should be made to recognize, control,
and prevent further spread of these infections, especially in areas
where hepatitis is endemic. Alpha interferon therapy hastens
disease remission in a proportion of patients with chronic
hepatitis B. Further studies are needed to define the role of
interferon in chronic HDV and HCV infection in children.
Author: Conjeevaram HS, Di Bisceglie AM,
Liver Diseases Section, National Institutes of Diabetes and
Digestive and Kidney Diseases, National Institutes of Health,
Bethesda, Maryland, USA. Source: J Pediatr Gastroenterol Nutr 20:
365-375 (1995)